Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABBV AbbVie	$189.50 -0.7%	$187.37	$163.63 ▼ $218.66	$334.34B	0.48	6.25 million shs	3.71 million shs
OKE ONEOK	$81.73 -0.5%	$82.27	$75.48 ▼ $118.07	$51.71B	0.93	3.44 million shs	1.76 million shs

2025 Gold Forecast: A Perfect Storm for Demand

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABBV AbbVie	0.00%	+4.19%	+1.17%	+1.57%	+15.66%
OKE ONEOK	0.00%	+0.56%	+1.38%	+1.24%	-1.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABBV AbbVie	4.9079 of 5 stars	3.4	5.0	3.3	3.9	2.8	1.7	1.3
OKE ONEOK	4.9802 of 5 stars	4.3	5.0	2.5	0.9	2.9	1.7	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABBV AbbVie	2.81	Moderate Buy	$211.29	11.50% Upside
OKE ONEOK	2.67	Moderate Buy	$104.08	27.35% Upside

Current Analyst Ratings Breakdown

Latest OKE and ABBV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/3/2025	OKE ONEOK	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$94.00 ➝ $97.00
6/11/2025	ABBV AbbVie	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$205.00
6/9/2025	ABBV AbbVie	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold	$204.00
6/5/2025	OKE ONEOK	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$96.00 ➝ $93.00
6/3/2025	OKE ONEOK	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$101.00 ➝ $91.00
5/20/2025	OKE ONEOK	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Outperform ➝ Sector Outperform	$100.00 ➝ $96.00
5/14/2025	ABBV AbbVie	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$210.00 ➝ $205.00
5/8/2025	ABBV AbbVie	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/6/2025	OKE ONEOK	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$110.00 ➝ $102.00
5/1/2025	OKE ONEOK	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$110.00 ➝ $107.00
5/1/2025	OKE ONEOK	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$102.00 ➝ $93.00

(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABBV AbbVie	$56.33B	5.94	$14.94 per share	12.68	$1.90 per share	99.74
OKE ONEOK	$21.70B	2.37	$7.10 per share	11.51	$37.89 per share	2.16

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABBV AbbVie	$4.28B	$2.35	80.64	13.56	1.26	7.31%	412.03%	13.11%	7/31/2025 (Estimated)
OKE ONEOK	$3.04B	$5.12	15.96	13.74	1.61	12.15%	15.58%	5.42%	8/4/2025 (Estimated)

Latest OKE and ABBV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	ABBV AbbVie	$3.24	N/A	N/A	N/A	$14.93 billion	N/A
4/29/2025	Q1 2025	OKE ONEOK	$1.28	$1.04	-$0.24	$1.04	$8.23 billion	$6.49 billion
4/25/2025	Q1 2025	ABBV AbbVie	$2.40	$2.46	+$0.06	$0.72	$12.91 billion	$13.34 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABBV AbbVie	$6.56	3.46%	N/A	279.15%	53 Years
OKE ONEOK	$4.12	5.04%	N/A	80.47%	3 Years

Latest OKE and ABBV Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/20/2025	ABBV AbbVie	quarterly	$1.64	3.54%	7/15/2025	7/15/2025	8/15/2025
4/24/2025	OKE ONEOK	quarterly	$1.03	4.78%	5/5/2025	5/5/2025	5/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABBV AbbVie	44.14	0.76	0.64
OKE ONEOK	1.35	0.67	0.52

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABBV AbbVie	70.23%
OKE ONEOK	69.13%

Insider Ownership

Company	Insider Ownership
ABBV AbbVie	0.25%
OKE ONEOK	0.21%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABBV AbbVie	55,000	1.77 billion	1.76 billion	Optionable
OKE ONEOK	5,177	629.54 million	628.22 million	Optionable

OKE and ABBV Headlines

Recent News About These Companies

ONEOK, Inc. (NYSE:OKE) Shares Acquired by Concurrent Investment Advisors LLC

5 hours ago | marketbeat.com

SL Advisors LLC Purchases 9,328 Shares of ONEOK, Inc. (NYSE:OKE)

July 5 at 8:25 AM | marketbeat.com

ONEOK, Inc. (NYSE:OKE) Shares Bought by Teacher Retirement System of Texas

July 5 at 5:22 AM | marketbeat.com

ONEOK (NYSE:OKE) Given New $97.00 Price Target at JPMorgan Chase & Co.

July 5 at 2:27 AM | americanbankingnews.com

Catalyst Capital Advisors LLC Acquires 217,001 Shares of ONEOK, Inc. (NYSE:OKE)

July 4 at 8:37 AM | marketbeat.com

IFM Investors Pty Ltd Buys 15,585 Shares of ONEOK, Inc. (NYSE:OKE)

July 4 at 8:03 AM | marketbeat.com

Royal Harbor Partners LLC Acquires Shares of 3,345 ONEOK, Inc. (NYSE:OKE)

July 4 at 7:27 AM | marketbeat.com

Avantax Planning Partners Inc. Raises Position in ONEOK, Inc. (NYSE:OKE)

July 4 at 7:27 AM | marketbeat.com

Aurora Private Wealth Inc. Purchases Shares of 11,008 ONEOK, Inc. (NYSE:OKE)

July 4 at 6:43 AM | marketbeat.com

ONEOK, Inc. (NYSE:OKE) Shares Acquired by Oregon Public Employees Retirement Fund

July 4 at 5:47 AM | marketbeat.com

3OKE : Analyst Expectations For ONEOK's Future

July 3 at 4:12 PM | benzinga.com

ONEOK (NYSE:OKE) Price Target Raised to $97.00 at JPMorgan Chase & Co.

July 3 at 9:30 AM | marketbeat.com

DAVENPORT & Co LLC Has $11.08 Million Holdings in ONEOK, Inc. (NYSE:OKE)

July 3 at 5:18 AM | marketbeat.com

ONEOK, Inc. (OKE) - Yahoo Finance

July 2 at 10:35 PM | finance.yahoo.com

Miller Howard Investments Inc. NY Acquires 4,029 Shares of ONEOK, Inc. (NYSE:OKE)

July 2 at 9:52 AM | marketbeat.com

Yukon Wealth Management Inc. Makes New $845,000 Investment in ONEOK, Inc. (NYSE:OKE)

July 2 at 6:58 AM | marketbeat.com

Sumitomo Mitsui DS Asset Management Company Ltd Increases Holdings in ONEOK, Inc. (NYSE:OKE)

July 2 at 6:37 AM | marketbeat.com

ET or OKE: Which Is the Better Value Stock Right Now?

July 1, 2025 | zacks.com

Industry Analysts Just Upgraded Their ONEOK, Inc. (NYSE:OKE) Revenue Forecasts By 11%

July 1, 2025 | finance.yahoo.com

Sage Advisors LLC Sells 4,284 Shares of ONEOK, Inc. (NYSE:OKE)

July 1, 2025 | marketbeat.com

Ameritas Advisory Services LLC Lowers Stake in ONEOK, Inc. (NYSE:OKE)

July 1, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

OKE and ABBV Company Descriptions

AbbVie NYSE:ABBV

$189.50 -1.25 (-0.66%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$188.90 -0.60 (-0.32%)

As of 07/3/2025 04:58 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

ONEOK NYSE:OKE

$81.72 -0.42 (-0.51%)

Closing price 07/3/2025 03:52 PM Eastern

Extended Trading

$81.72 0.00 (0.00%)

As of 07/3/2025 04:43 PM Eastern

ONEOK, Inc. engages in gathering, processing, fractionation, storage, transportation, and marketing of natural gas and natural gas liquids (NGL) in the United States. It operates through four segments: Natural Gas Gathering and Processing, Natural Gas Liquids, Natural Gas Pipelines, and Refined Products and Crude. The company owns natural gas gathering pipelines and processing plants in the Mid-Continent and Rocky Mountain regions; and provides midstream services to producers of NGLs. It also owns NGL gathering and distribution pipelines in Oklahoma, Kansas, Texas, New Mexico, Montana, North Dakota, Wyoming, and Colorado; terminal and storage facilities in Kansas, Nebraska, Iowa, and Illinois; NGL distribution pipelines in Kansas, Nebraska, Iowa, Illinois, and Indiana; transports refined petroleum products, including unleaded gasoline and diesel; and owns and operates truck- and rail-loading, and -unloading facilities connected to NGL fractionation, storage, and pipeline assets. In addition, the company transports and stores natural gas through regulated interstate and intrastate natural gas transmission pipelines, and natural gas storage facilities. Further, it owns and operates a parking garage in downtown Tulsa, Oklahoma; and leases excess office space and rail cars. Additionally, the company transports, stores, and distributes refined products, NGLs, and crude oil, as well as conducts commodity-related activities, including liquids blending and marketing activities. It serves integrated and independent exploration and production companies; other NGL and natural gas gathering and processing companies; crude oil and natural gas production companies; utilities; industrial companies; natural gasoline distributors; propane distributors; municipalities; ethanol producers; petrochemical, refining, and marketing companies; and heating fuel users, refineries, and exporters. ONEOK, Inc. was founded in 1906 and is headquartered in Tulsa, Oklahoma.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time